Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials
| Image |  |
|---|---|
| Description | scientific article published on 04 March 2014 |
| Author/s |
author: Robert P Giugliano Robert Scott |
| Publication date | March 4, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |